Symphysis Medical

Developing innovative technologies that treat a broad range of chronic diseases.


CEO and Co-founder Tim Jones 

CSO and Co-founder Michelle Tierney

Tim Jones and Michelle Tierney are co-founders of SymPhysis Medical.  Founded in 2019, SymPhysis Medical first came in contact with Furthr when they applied for the One2Watch competition as a part of Furthr’s annual conference, Furthr Festival (formerly Futurescope). Michelle and Tim demonstrated a clear market and clinical need and have gone on to build out a strong team and win numerous industry awards. 

SymPhysis Medical’s emergent technology, Releaze, is a drainage technology to treat a common complication of late-stage cancers known as malignant pleural effusion (MPE).  MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.  SymPhysis Medical’s goal is to develop innovative technologies that treat a broad range of chronic diseases.  

To help achieve this goal, Furthr VC  assisted SymPhysis Medical in raising more than €1.9m in funding in April 2022.  The Investment round was led by the Halo Business Angel Network (HBAN), and a joint initiative of Enterprise Ireland, InterTradeIreland and Invest Northern Ireland.  Business angels in three HBAN syndicates–the Medtech Syndicate, Irrus Investments and Boole Investment Syndicate–invested a combined €925,000, alongside Furthr VC, Enterprise Ireland and a private investor.

With this funding, SymPhysis Medical is able to continue putting the patient experience at the forefront of their design solutions to improve quality of life.

Latest Stories

What are you looking for?

Popular Searches